Kestra Medical Technologies (KMTS) Change in Accured Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Change in Accured Expenses data on file, last reported at $3.7 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $3.7 million, up 288.98% year-over-year; the trailing twelve-month figure through Jan 2026 was $6.1 million (up 56.63% YoY), and the FY2025 annual result was $4.6 million, up 1144.47% from the prior year.
• Change in Accured Expenses grew to $3.7 million in Q1 2026 per KMTS's latest filing, from $1.4 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $3.7 million in Q1 2026 and troughed at -$860000.0 in Q3 2025.
• A 3-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses plunged 714.29% in 2025, then soared 288.98% in 2026.
• A 3-year view of Change in Accured Expenses shows it stood at $1.6 million in 2024, then fell by 16.16% to $1.4 million in 2025, then jumped by 166.09% to $3.7 million in 2026.
• Business Quant data shows KMTS's Change in Accured Expenses at $3.7 million in Q1 2026, $1.4 million in Q4 2025, and -$860000.0 in Q3 2025.